Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-interleukin-2 receptor subunit gamma monoclonal antibody REGN7257

A monoclonal antibody targeted against interleukin-2 (IL-2) receptor subunit gamma (IL2RG; CD132; cytokine receptor common subunit gamma; gamma chain; gc), with potential immunomodulatory activity. Upon administration, anti-IL2RG monoclonal antibody REGN7257 targets and binds to the gamma subunit of the human IL-2 receptor (IL-2R) expressed on the surface of activated T lymphocytes, thereby inhibiting IL-2 binding and IL-2-mediated T-cell activation. This may block T-cell-mediated immune responses. IL2RG plays a role in both immune responses and interleukin signaling.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-cytokine receptor common subunit gamma monoclonal antibody REGN7257
anti-gamma chain receptor monoclonal antibody REGN7257
anti-IL2RG monoclonal antibody REGN7257
Code name:REGN 7257
REGN-7257
REGN7257
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search